Ohlmer A, Leger R, Scheiderer U, Elfeldt R, Wulf H
Klinik für Anästhesiologie und Operative Intensivmedizin, Christian-Albrechts-Universität Kiel.
Anaesthesiol Reanim. 1997;22(6):159-63.
Both regional analgesia and systemic opioid therapy (e.g. PCA) are commonly used for pain relief following thoracic surgery. Many anaesthesiologists are reluctant to use thoracic epidural analgesia on general surgical wards. Therefore, we investigated in a prospective randomised study the efficacy of intercostal blocks (ICB) or interpleural analgesia (IPA) compared to PCA with systemic opioids (PCA). Following ethics committee approval and informed consent, 45 thoracotomy patients were randomised for postoperative pain management: group 1: intravenous PCA with piritramide (PCA-control), group 2: intercostal blocks of the segments concerned with 5 ml bupivacaine 0.5% at the end of surgery and 6 hours thereafter (ICB), group 3: interpleural analgesia with 20 ml bupivacaine 0.25% applied every 4 hours using a catheter placed during surgery near the apex of the pleural space (IPA). Patients in the ICB and IPA groups were able to obtain additional pain relief by PCA with piritramide. Alternative medication for all groups in case of insufficient analgesia was metamizol. Both regional analgesia groups used significantly less piritramide up to the 3rd (IPA) or 7th (ICB) postoperative day than the control group (p < 0.05). The consumption of metamizol was lower as well (n. s.). No significant differences between the study groups were observed with regard to pain scores (visual analogue scale VAS) at rest, during deep inspiration, coughing or mobilisation. Respiratory parameters as forced vital capacity, forced expiratory volume (1 sec) and peak flow (FVC; FEV1; PF) were reduced significantly following thoracotomy and showed a slow restitution in all three study groups without major inter-group differences. Intercostal blocks and interpleural analgesia significantly reduce opioid demand following thoracotomy and are effective means of postoperative pain management. Nevertheless, in contrast to epidural analgesia, both methods have to be supplemented by, or combined with, systemic analgesics in most patients. On the other hand, compared to epidural analgesia, ICB and IPA are less invasive and easier to manage on general surgical wards.
区域镇痛和全身性阿片类药物治疗(如PCA)常用于胸科手术后的疼痛缓解。许多麻醉医生不愿在普通外科病房使用胸段硬膜外镇痛。因此,我们进行了一项前瞻性随机研究,比较肋间阻滞(ICB)或胸膜间镇痛(IPA)与全身性阿片类药物PCA的疗效。经伦理委员会批准并获得知情同意后,45例开胸手术患者被随机分组进行术后疼痛管理:第1组:静脉注射匹米诺定PCA(PCA对照组);第2组:在手术结束时及术后6小时用5ml 0.5%布比卡因对相关节段进行肋间阻滞(ICB);第3组:通过在手术期间置于胸膜腔顶部附近的导管每4小时注入20ml 0.25%布比卡因进行胸膜间镇痛(IPA)。ICB组和IPA组的患者可通过注射匹米诺定PCA获得额外的疼痛缓解。若镇痛不足,所有组的替代药物均为安乃近。在术后第3天(IPA组)或第7天(ICB组)之前,两个区域镇痛组使用的匹米诺定均明显少于对照组(p<0.05)。安乃近的消耗量也较低(无统计学意义)。在静息、深吸气、咳嗽或活动时的疼痛评分(视觉模拟量表VAS)方面,各研究组之间未观察到显著差异。开胸手术后,用力肺活量、第1秒用力呼气量和峰值流速(FVC;FEV1;PF)等呼吸参数显著降低,且在所有三个研究组中均显示出缓慢恢复,组间无重大差异。肋间阻滞和胸膜间镇痛可显著降低开胸手术后的阿片类药物需求量,是术后疼痛管理的有效方法。然而,与硬膜外镇痛不同,在大多数患者中,这两种方法都必须辅以全身性镇痛药或与之联合使用。另一方面,与硬膜外镇痛相比,ICB和IPA的侵入性较小,在普通外科病房更易于管理。